Total Visits
| Views | |
|---|---|
| Patient-reported ... | 150 |
Total Visits Per Month
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| Patient-reported ... | 2 | 17 | 2 | 11 | 2 | 14 | 7 |
File Visits
| Views | |
|---|---|
| patient_reported_outcomes_tolerability_patients_receiving_ripretinib_versus_sunitinib_after_treatment_imatinib_intrigue_a_phase_3_open_label_study_2023_material_suplementari.pdf | 53 |
| patient_reported_outcomes_tolerability_patients_receiving_ripretinib_versus_sunitinib_after_treatment_imatinib_intrigue_a_phase_3_open_label_study_2023.pdf | 49 |
Top country views
| Views | |
|---|---|
| United States | 77 |
| China | 16 |
| Singapore | 15 |
| Hong Kong | 10 |
| United Kingdom | 7 |
| France | 6 |
| Germany | 5 |
| Spain | 3 |
| Ireland | 2 |
| Mexico | 2 |
Top cities views
| Views | |
|---|---|
| Singapore | 13 |
| Beijing | 12 |
| Ashburn | 9 |
| Hong Kong | 9 |
| Dallas | 8 |
| Los Angeles | 8 |
| Boydton | 5 |
| Buffalo | 5 |
| Paris | 5 |
| Orangeburg | 4 |



